Showing results (321-330 of 541) with videos related to
Sort By:
Pageof 55
AIDS (London, England)|February 16, 2012
Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patientsSarah Maylin, Anders Boyd, Fabien Lavocat, et al.Journal of Hepatology|December 15, 2010
Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intakeMarie-Pierre Lambert, Anupam Paliwal, Thomas Vaissière, et al.Journal of Hepatology|March 17, 2023
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In CirrhoticsMaria Paola Anolli, Elisabetta Degasperi, Lena Allweiss, et al.Hepatology (Baltimore, Md.)|November 3, 2020
Association of Metabolic Risk Factors With Risks of Cancer and All-Cause Mortality in Patients With Chronic Hepatitis BYun Bin Lee, Hyemi Moon, Jeong-Hoon Lee, et al.Cancer Prevention Research (Philadelphia, Pa.)|February 20, 2021
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative ManagementPierre Nahon, Richard Layese, Carole Cagnot, et al.The Journal of General Virology|March 22, 2007
Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitorsCynthia Chapel, Céline Garcia, Birke Bartosch, et al.Journal of Hepatology|December 4, 2013
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patientsThomas Berg, Fabien Zoulim, Bernd Moeller, et al.Journal of Hepatology|July 7, 2015
Expression and functionality of Toll- and RIG-like receptors in HepaRG cellsSouphalone Luangsay, Malika Ait-Goughoulte, Maud Michelet, et al.Plos Pathogens|February 21, 2009
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsMarlène Dreux, Viet Loan Dao Thi, Judith Fresquet, et al.Hepatology (Baltimore, Md.)|April 27, 2017
Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replicationAhmed Diab, Adrien Foca, Floriane Fusil, et al.Pageof 55